Kawasaki Sachiko, Shigematsu Hideki, Ikejiri Masaki, Mui Takahiro, Okuda Akinori, Masuda Keisuke, Ueda Yurito, Tanaka Yasuhito
Nara Medical University, Nara, Japan.
Kashibaasahigaoka Hospital, Nara, Japan.
Eur Spine J. 2025 Aug 4. doi: 10.1007/s00586-025-09199-9.
To determine the duration required to achieve an "effective" status on each domain of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) for patients who underwent laminoplasty to treat cervical spondylotic myelopathy (CSM) and identify predictive factors influencing the domain-specific recovery of these patients.
We prospectively recruited 84 patients with CSM who underwent laminoplasty at two institutions between 2018 and 2020. JOACMEQ scores were recorded preoperatively and at 1, 3, 6 months, and 1 and 2 years postoperatively. The cumulative incidence of achieving an "effective" status--defined as either a ≥ 20-point increase in the domain score or a post-treatment score > 90 for patients with baseline scores < 90--was analyzed using the Kaplan-Meier method. For each domain, we evaluated the association of preoperative risk factors with time to achieve an "effective" status of postoperative outcomes.
Eighty-two patients were examined (61 men and 21 women; mean age: 70 years). The median time to achieve 50% "effective" status varied significantly across JOACMEQ domains (p = 0.006). Bladder function (12 months) and quality of life (QOL) (not reached) improved more slowly than cervical, upper, and lower extremity function (3 months). The univariate analysis indicated a significant association between sex and QOL improvement (p = 0.040); however, this association was not significant in the multivariate analysis.
This is the first prospective study examining recovery based on the domain-specific "effective" criteria in patients who underwent laminoplasty for CSM. Bladder function and QOL required a longer time to achieve an "effective" status than other JOACMEQ domains. Male sex may be a potential risk factor for delayed QOL improvement. The findings may be useful for preoperative counseling of men with CSM.
确定接受椎板成形术治疗脊髓型颈椎病(CSM)的患者在日本骨科协会脊髓型颈椎病评估问卷(JOACMEQ)各领域达到“有效”状态所需的时间,并确定影响这些患者特定领域恢复的预测因素。
我们前瞻性招募了84例在2018年至2020年间于两家机构接受椎板成形术的CSM患者。术前及术后1、3、6个月以及1年和2年记录JOACMEQ评分。使用Kaplan-Meier方法分析达到“有效”状态的累积发生率,“有效”状态定义为领域评分增加≥20分或基线评分<90分的患者治疗后评分>90分。对于每个领域,我们评估术前危险因素与术后达到“有效”状态时间的相关性。
检查了82例患者(61例男性和21例女性;平均年龄:70岁)。在JOACMEQ各领域中,达到50%“有效”状态的中位时间差异显著(p = 0.006)。膀胱功能(12个月)和生活质量(QOL)(未达到)的改善比颈、上肢和下肢功能(3个月)更慢。单因素分析表明性别与QOL改善之间存在显著相关性(p = 0.040);然而,在多因素分析中这种相关性不显著。
这是第一项基于特定领域“有效”标准对接受CSM椎板成形术患者的恢复情况进行研究的前瞻性研究。膀胱功能和QOL达到“有效”状态所需的时间比JOACMEQ其他领域更长。男性可能是QOL改善延迟的潜在危险因素。这些发现可能有助于对CSM男性患者进行术前咨询。